MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial

Published:2018-07 Issue:7 Volume:19 Page:916-929
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Dreno Brigitte,Thompson John F,Smithers Bernard Mark,Santinami Mario,Jouary Thomas,Gutzmer Ralf,Levchenko Evgeny,Rutkowski Piotr,Grob Jean-Jacques,Korovin Sergii,Drucis Kamil,Grange Florent,Machet Laurent,Hersey Peter,Krajsova Ivana,Testori Alessandro,Conry Robert,Guillot Bernard,Kruit Wim H J,Demidov Lev,Thompson John A,Bondarenko Igor,Jaroszek Jaroslaw,Puig Susana,Cinat Gabriela,Hauschild Axel,Goeman Jelle J,van Houwelingen Hans C,Ulloa-Montoya Fernando,Callegaro Andrea,Dizier Benjamin,Spiessens Bart,Debois Muriel,Brichard Vincent G,Louahed Jamila,Therasse Patrick,Debruyne Channa,Kirkwood John M

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Final version of 2009 AJCC melanoma staging and classification;Balch;J Clin Oncol,2009

2. Adjuvant low-dose interferon {alpha}2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis;Garbe;Ann Oncol,2008

3. Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma;Eggermont;J Clin Oncol,2012

4. Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy;Eggermont;N Engl J Med,2016

5. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma;Weber;N Engl J Med,2017

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteogenomics offers a novel avenue in neoantigen identification for cancer immunotherapy;International Immunopharmacology;2024-12

2. Cationic pH-sensitive liposome-based subunit tuberculosis vaccine induces protection in mice challenged with Mycobacterium tuberculosis;European Journal of Pharmaceutics and Biopharmaceutics;2024-10

3. Gemcitabine Resistant Triple Negative Breast Tumor Derived Mesoporous Silicon Nanovaccine Overcame Drug Resistance;Advanced Functional Materials;2024-09-13

4. Recent Advancements in Cell-Based Therapies in Melanoma;International Journal of Molecular Sciences;2024-09-12

5. A Multi‐Functional Nanoadjuvant Coupling Manganese with Toll‐Like 9 Agonist Stimulates Potent Innate and Adaptive Anti‐Tumor Immunity;Advanced Science;2024-09-11